ME02035B - Antivirusne smješe koje sadrže geraniol i karvin - Google Patents

Antivirusne smješe koje sadrže geraniol i karvin

Info

Publication number
ME02035B
ME02035B MEP-2012-533A MEP53312A ME02035B ME 02035 B ME02035 B ME 02035B ME P53312 A MEP53312 A ME P53312A ME 02035 B ME02035 B ME 02035B
Authority
ME
Montenegro
Prior art keywords
carvone
geraniol
antiviral compositions
antiviral
compositions
Prior art date
Application number
MEP-2012-533A
Other languages
German (de)
English (en)
French (fr)
Inventor
Christine Coppens
Original Assignee
Cesa Alliance Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42102951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME02035(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cesa Alliance Sa filed Critical Cesa Alliance Sa
Publication of ME02035B publication Critical patent/ME02035B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MEP-2012-533A 2010-03-26 2010-03-26 Antivirusne smješe koje sadrže geraniol i karvin ME02035B (me)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10157930A EP2368547B1 (en) 2010-03-26 2010-03-26 Antiviral compositions comprising geraniol and carvone

Publications (1)

Publication Number Publication Date
ME02035B true ME02035B (me) 2013-04-30

Family

ID=42102951

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2012-533A ME02035B (me) 2010-03-26 2010-03-26 Antivirusne smješe koje sadrže geraniol i karvin

Country Status (35)

Country Link
US (2) US8980945B2 (me)
EP (2) EP2368547B1 (me)
JP (1) JP5342085B2 (me)
KR (1) KR101340260B1 (me)
CN (1) CN102946876B (me)
AU (1) AU2011231511B2 (me)
BR (1) BR112012024260B1 (me)
CA (1) CA2790087C (me)
CL (1) CL2012002606A1 (me)
CO (1) CO6602166A2 (me)
CY (3) CY1113449T1 (me)
DK (2) DK2368547T3 (me)
EA (1) EA025278B9 (me)
ES (2) ES2392938T3 (me)
HK (1) HK1176019A1 (me)
HR (2) HRP20120964T1 (me)
HU (1) HUE026121T2 (me)
IL (1) IL222048A (me)
LU (1) LU91805B1 (me)
MA (1) MA34074B1 (me)
ME (1) ME02035B (me)
MX (1) MX346412B (me)
MY (2) MY153104A (me)
NZ (1) NZ602602A (me)
PE (2) PE20130065A1 (me)
PL (2) PL2368547T3 (me)
PT (2) PT2368547E (me)
RS (2) RS52544B (me)
SG (1) SG184039A1 (me)
SI (2) SI2368547T1 (me)
SM (2) SMT201200062B (me)
TN (2) TN2012000444A1 (me)
UA (1) UA102497C2 (me)
WO (1) WO2011117424A1 (me)
ZA (2) ZA201208116B (me)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013064360A2 (en) 2011-11-03 2013-05-10 Unilever N.V. A personal cleaning composition
WO2013083595A1 (en) 2011-12-06 2013-06-13 Unilever N.V. Antimicrobial composition
CN104080341B (zh) 2011-12-06 2017-09-22 荷兰联合利华有限公司 抗微生物组合物
WO2013083583A1 (en) 2011-12-06 2013-06-13 Unilever N.V. Antimicrobial composition
CN104378988B (zh) * 2012-06-27 2017-09-05 荷兰联合利华有限公司 抗微生物组合物
RU2533254C2 (ru) * 2012-12-29 2014-11-20 Федеральное государственное бюджетное учреждение научно-исследовательский институт детских инфекций Федерального медико-биологического агентства Способ лечения неврологических осложнений при ветряной оспе у детей
TWI463979B (zh) * 2013-04-12 2014-12-11 Nat Defense Medical Ct 檸檬醛用於製備治療局部腎絲球硬化症之藥物的用途
KR20150145314A (ko) 2014-06-18 2015-12-30 원광대학교산학협력단 카르본을 유효성분으로 포함하는 항균 조성물
CN106727628A (zh) * 2016-12-17 2017-05-31 郑州郑先医药科技有限公司 一种治疗慢性腹泻的西药组合物
KR101970281B1 (ko) * 2017-07-28 2019-04-18 고려대학교 산학협력단 리나릴 아세테이트를 포함하는 올메사탄으로 유발된 장운동과다증의 예방 또는 치료용 조성물
CN107648488A (zh) * 2017-09-29 2018-02-02 陈晓阳 一种用于治疗慢性咽炎的丸剂
KR102118181B1 (ko) * 2018-06-12 2020-06-02 광주여자대학교 산학협력단 식물성 정유를 유효성분으로 포함하는 a형 인플루엔자 바이러스에 대한 항바이러스 조성물
RU2707950C1 (ru) * 2018-11-28 2019-12-02 Общество с ограниченной ответственностью "ЭРБИ" Средство для обработки среды пребывания птицы на основе липосом с фитокомпозицией с иммунотропным действием и избирательным антисептическим эффектом и способ его применения
US20200179299A1 (en) * 2018-12-07 2020-06-11 Global Biolife Inc. Composition and method of controlling infectious diseases with functional fragrances
CN110496117B (zh) * 2019-09-30 2022-09-06 中国科学院微生物研究所 一种小分子化合物在抗非洲猪瘟病毒感染中的新应用
CN111012769B (zh) * 2019-12-05 2021-02-12 青海大学 一种用于治疗包虫病的药物组合物、药物制剂及乳剂制备方法
WO2021224947A1 (en) * 2020-05-02 2021-11-11 Norouzi Mehdi Formulation of acute respiratory disease control formulation
CN114716327A (zh) * 2020-12-14 2022-07-08 中南民族大学 柏木醇衍生物、其制备方法及其应用
CA3102947A1 (en) * 2020-12-18 2022-06-18 Skymount Medical Us Inc. Nutraceuticals useful in the treatment of coronavirus diseases
JP7133820B1 (ja) * 2021-06-09 2022-09-09 塩野香料株式会社 コロナウイルス感染症予防用香料組成物及び結合阻害剤
CN113994963B (zh) * 2021-09-26 2023-04-28 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) 一种含有乙酸二氢香芹酯的抑芽剂及其用途
TWI800937B (zh) * 2021-10-01 2023-05-01 奇美醫療財團法人奇美醫院 用於治療登革熱病毒感染之方法
CN117338758B (zh) * 2023-12-06 2024-03-12 北京远大九和药业有限公司 一种药物组合物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5667M (me) 1966-03-10 1968-01-02
LU78955A1 (de) 1978-01-27 1979-09-06 Chimicasa Gmbh Verfahren zur inaktivierung von viren
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO2002056879A1 (en) * 2001-01-03 2002-07-25 Medpharma Plc Use of terpenes for the treatment of digestive tract infections
US20040071757A1 (en) * 2001-11-20 2004-04-15 David Rolf Inhalation antiviral patch
WO2007063268A1 (en) * 2005-11-30 2007-06-07 Eden Research Plc Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone
WO2008086477A1 (en) * 2007-01-10 2008-07-17 The Regents Of The University Of Michigan Ultrafiltration membrane, device, bioartificial organ, and related methods
KR100796312B1 (ko) * 2007-05-23 2008-01-21 주식회사 바이오미스트테크놀로지 게라니얼，네랄 및 유게놀을 유효성분으로 함유하는 동물용소독제 조성물
KR100950428B1 (ko) 2008-06-05 2010-04-02 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 디아릴헵타노이드계 화합물
KR100941595B1 (ko) 2008-06-05 2010-02-11 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 트리테르페노이드계 화합물

Also Published As

Publication number Publication date
MY158757A (en) 2016-11-15
PT2368547E (pt) 2012-11-20
ZA201208116B (en) 2014-04-30
CA2790087C (en) 2013-07-30
RS53435B (en) 2014-12-31
MY153104A (en) 2014-12-31
TN2013000366A1 (en) 2015-01-20
ES2392938T3 (es) 2012-12-17
PT2555763E (pt) 2014-08-04
PE20141008A1 (es) 2014-09-20
SI2555763T1 (sl) 2014-08-29
EP2555763B1 (en) 2014-04-30
HRP20120964T1 (en) 2012-12-31
US20130225676A1 (en) 2013-08-29
HK1176019A1 (en) 2013-07-19
CA2790087A1 (en) 2011-09-29
UA102497C2 (ru) 2013-07-10
KR20120128716A (ko) 2012-11-27
LU91805B1 (fr) 2011-09-26
EP2368547A1 (en) 2011-09-28
CY1115375T1 (el) 2017-01-04
AU2011231511B2 (en) 2014-03-20
PL2368547T3 (pl) 2013-02-28
EA201270749A1 (ru) 2013-03-29
SG184039A1 (en) 2012-10-30
SMT201400104B (it) 2014-09-08
MX2012010949A (es) 2013-01-29
PL2555763T3 (pl) 2014-09-30
TN2012000444A1 (en) 2014-01-30
DK2368547T3 (da) 2013-01-02
KR101340260B1 (ko) 2013-12-10
NZ602602A (en) 2012-12-21
BR112012024260A2 (pt) 2016-07-12
EP2368547B1 (en) 2012-09-12
ZA201306926B (en) 2014-04-30
MX346412B (es) 2017-03-17
CY1113449T1 (el) 2016-06-22
EP2555763A1 (en) 2013-02-13
EA025278B1 (ru) 2016-12-30
DK2555763T3 (da) 2014-08-04
SI2368547T1 (sl) 2013-01-31
JP5342085B2 (ja) 2013-11-13
MA34074B1 (fr) 2013-03-05
CO6602166A2 (es) 2013-01-18
CN102946876B (zh) 2016-04-06
SMT201200062B (it) 2013-03-08
IL222048A (en) 2014-09-30
BR112012024260B1 (pt) 2019-12-31
US8980945B2 (en) 2015-03-17
CL2012002606A1 (es) 2013-10-18
CY1119841T1 (el) 2018-06-27
HUE026121T2 (en) 2016-05-30
RS52544B (en) 2013-04-30
HRP20140706T1 (hr) 2014-09-12
JP2013523622A (ja) 2013-06-17
EA025278B9 (ru) 2017-03-31
CN102946876A (zh) 2013-02-27
PE20130065A1 (es) 2013-03-08
US8883859B1 (en) 2014-11-11
WO2011117424A1 (en) 2011-09-29
AU2011231511A1 (en) 2012-10-18
ES2486765T3 (es) 2014-08-19

Similar Documents

Publication Publication Date Title
ME02035B (me) Antivirusne smješe koje sadrže geraniol i karvin
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
IL237664A0 (en) Preparations for pest control and related processes
ZA201209259B (en) Uses and compositions
IL227625A0 (en) Nanoparticle compounds, their formulations, and their use
IL228322A0 (en) History of dispiropyrrolidine, preparations containing them and their uses
IL226081A0 (en) Preparations for pest control and related processes
IL222316A0 (en) Edible composition and uses thereof
IL223361A (en) Purinone history, preparations containing them and their uses
EP2550307A4 (en) MACRO-PHOTOINITIATORS AND COMPOSITIONS CURABLE THEREOF
IL223153A0 (en) Compositions comprising acid and derivatives thereof and uses thereof
GB201006096D0 (en) Novel compositions and uses thereof
GB201009368D0 (en) Dietary formulations
PL2579839T3 (pl) Kompozycje perfumeryjne i ich zastosowania
PL2605757T3 (pl) Preparaty oparte na nalbufinie i ich zastosowania
EP2588117A4 (en) STABLE ANTISEPTIC COMPOSITIONS AND METHODS
HK1209636A1 (en) Trans-clomiphene formulations and uses thereof (trans-clomiphene)
IL223405B (en) Phosphoplatins, preparations containing them and their uses
PL2646520T3 (pl) Kompozycja na bazie 1,1,1,4,4,4-heksafluorobut-2-enu i 3,3,4,4,4-pentafluorobut-1-enu
EP2753341A4 (en) ANTIMICROBIAL COMPOSITIONS AND USES THEREOF
HK1186680A1 (zh) 包含泡桐素和/或泡桐屬提取物的組合物及其用途
EP2874641A4 (en) COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF
IL225724A0 (en) Aceylbenzene history, leases containing them and their uses
IL235154A0 (en) Preparations containing substances to reduce uric acid and anti-inflammatory substances and their uses
GB201019291D0 (en) Compositions and uses